Exelixis Announces EMA Acceptance of Marketing Authorization...
Exelixis, Inc. today announced the European Medicines Agency has accepted for review the Marketing Authorization Application for COMETRIQ for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer .
Join the discussion below, or Read more at Freshnews.
#1 Nov 30, 2012
Looking for more information on Cometriq? Here's a pharmacist's description: http://www.rxwiki.com/cometriq
#2 Dec 13, 2012
We don't have the time to keep up with the current marketing trends. We are looking for a marketing firm grand rapids who is forward thinking. Any recommendations?
Add your comments below
|Lawmakers revisiting requiring those on Medicai...||26 min||ardith||139|
|AIDS Walk New York and Gay Men's Health Crisis:...||59 min||Dooley||30|
|Republicans already giving Trump's budget a col...||1 hr||Trade her off||11|
|Pregnancy Symptoms - 12 Very Early Symptoms of ... (Jun '07)||1 hr||Kagome15||7,205|
|1st city to ban smoking inside restaurants, Win...||1 hr||Sanjay||59|
|Trump's proposed $4.1 trillion budget slashes f...||1 hr||Pence||2|
|Medicaid cuts coming in Trump budget - Washingt...||2 hr||ardith||1|
|Nudity at doctor's office (Mar '07)||May 19||SissyBareFeet||169|
Find what you want!
Search Health Forum Now
Copyright © 2017 Topix LLC